Results 241 to 250 of about 136,515 (265)

Comparative Analysis of Interim Measures —

2022
Vivek Jain, Thomas Macey-Dare QC, Shengnan Jia   +2 more
openaire   +1 more source

Determinants of narrative risk disclosures in UK interim reports

Journal of Risk Finance, 2012
Hany Elzahar, Khaled Hussainey
exaly  

The reassessment of trial perspectives from interim data—a critical view

Statistics in Medicine, 2006
Peter Bauer, Franz König
exaly  

The impact of CEO turnover on firm performance around interim successions

Journal of Management and Governance, 2012
Andrew Zhang, Vincent J Intintoli, Wallace N Davidson   +2 more
exaly  

Impact of interim progression during the surgery-to-radiotherapy interval and its predictors in glioblastoma treated with temozolomide-based radiochemotherapy

Journal of Neuro-Oncology, 2017
Tae Min Kim, Eunji Kim, Chan Woo Wee
exaly  

interim analysis

2009
openaire   +1 more source

Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010–2014

Vaccine, 2015
Amparo Larrauri, Francisco Pozo, Silvia Jiménez-Jorge   +2 more
exaly  

Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP

Annals of Hematology, 2010
Jeong Eun Kim, Changhoon Yoo, Byeong Seok Sohn   +2 more
exaly  

Interim Analysis

2010
openaire   +1 more source

Prognostic value of interim FDG PET/CT in Hodgkin’s lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria

European Journal of Nuclear Medicine and Molecular Imaging, 2011
Solène Querellou, Caroline Bodet-Milin, Pierre-Yves Le Roux   +2 more
exaly